Z-1775-2021 Class II Terminated
FDA device recall Z-1775-2021 was initiated by Fujifilm Medical Systems U.S.A., Inc. on Apr 30, 2021 and is designated Class II. Reason for recall: Software versions 6.0.4 to 6.2.1 using Advanced Reporting -possibility that a previously assigned internal patient database ID can be reused for a new patient. It was discovered that this value does… The recall status is terminated (terminated Jul 29, 2024). Affected quantity: 44 US and 4 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Jun 9, 2021
- Initiation Date
- Apr 30, 2021
- Termination Date
- Jul 29, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 44 US and 4 OUS
Product description
Synapse Cardiovascular (Synapse CV). Software Versions: 6.0 to 6.2.1 The Synapse Cardiovascular image is a management and reporting system
Reason for recall
Software versions 6.0.4 to 6.2.1 using Advanced Reporting -possibility that a previously assigned internal patient database ID can be reused for a new patient. It was discovered that this value does not increase when a patient merge activity is executed in a specific sequence
Distribution pattern
Worldwide distribution - US Nationwide distribution and the countries of Canada, Bermuda, Israel, Hadassah Medical Center.
Code information
Software Versions: 6.0 to 6.2.1
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1775-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026